Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serum free light chain reduction correlates with response and progression-free survival following carfilzomib therapy in relapsed/refractory multiple myeloma.

× No keyword cloud information.

2 in total

1. A Tumor Growth Inhibition Model Based on M-Protein Levels in Subjects With Relapsed/Refractory Multiple Myeloma Following Single-Agent Carfilzomib Use.

Authors: F Jonsson; Y Ou; L Claret; D Siegel; S Jagannath; R Vij; A Badros; S Aggarwal; R Bruno
Journal: CPT Pharmacometrics Syst Pharmacol Date: 2015-11-20

2. Early M-Protein Dynamics Predicts Progression-Free Survival in Patients With Relapsed/Refractory Multiple Myeloma.

Authors: Xiaoyu Yan; Xu Steven Xu; Katja C Weisel; Maria-Victoria Mateos; Pieter Sonneveld; Meletios A Dimopoulos; Saad Zafar Usmani; Nizar J Bahlis; Thomas Puchalski; Jon Ukropec; Kevin Bellew; Qi Ming; Steven Sun; Honghui Zhou
Journal: Clin Transl Sci Date: 2020-07-17 Impact factor: 4.689

2 in total